Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy

Journal of Gastroenterology

Volumn 42, Issue 9, 2007, Pages 730-736

  Ojima, Eiki ^a   Inoue, Yasuhiro ^a   Miki, Chikao ^a   Mori, Masaki ^b   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; PTMA (prothymosin ); Radiation related genes

Indexed keywords

FLUOROURACIL; INITIATION FACTOR 5A; PROTHYMOSIN ALPHA; UFT;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SEQUENCE; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOSENSITIVITY; RECTUM CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; UPREGULATION;

AGED; BIOPSY; COLECTOMY; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDE INITIATION FACTORS; PREOPERATIVE CARE; PROGNOSIS; PROTEIN PRECURSORS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; RNA-BINDING PROTEINS; THYMOSIN; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 34648817252     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-007-2089-x     Document Type: Article

References (34)

1. NIH consensus conference 1990 Adjuvant therapy for patients with colon and rectal cancer JAMA 264 1444-50 10.1001/jama.264.11.1444
2. FR Spitz GG Giacco K Hess L Larry TA Rich N Janjan 1997 p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer Clin Cancer Res 3 1685-90 9815551 1:STN:280:DyaK1M7htFWjuw%3D%3D
3. P Luna-Perez EL Arriola Y Cuadra I Alvarado A Quintero 1998 p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma Ann Surg Oncol 5 203-8 9607618 10.1007/BF02303772 1:STN:280:DyaK1c3mvVKgtg%3D%3D
4. A Tannapfel S Nusslein R Fietkau A Katalinic F Kockerling C Wittekind 1998 Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer Int J Radiat Oncol Biol Phys 41 585-91 9635706 10.1016/ S0360-3016(98)00076-5 1:STN:280:DyaK1c3pslKhuw%3D%3D
5. H Elsaleh P Robbins D Joseph B Powell F Grieu L Menso 2000 Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer? Radiother Oncol 56 239-44 10927144 10.1016/S0167-8140(00)00184-5 1:CAS:528:DC%2BD3cXltleksbs%3D
6. NK Kim JK Park KY Lee WI Yang SH Yun J Sung 2001 p53, BCL-2, and Ki-67 expression according to tumor response after concurrent chemoradiotherapy for advanced rectal cancer Ann Surg Oncol 8 418-24 11407516 10.1007/s10434-001-0418-5 1:STN:280:DC%2BD3MzksVGhug%3D%3D
7. RP Saw M Morgan D Koorey D Painter M Findlay G Stevens 2003 p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy Dis Colon Rectum 46 192-202 12576893 10.1007/s10350-004-6524-2
8. G Esposito S Pucciarelli R Alaggio L Giacomelli E Marchiori GA Iaderosa 2001 P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer Ann Surg Oncol 8 311-8 11352304 10.1007/s10434-001-0311-2 1:STN:280:DC%2BD3M3lsVWguw%3D%3D
9. K Gunther A Dimmler F Rodel U Reulbach S Merkel BR Bittorf 2003 P27 does not predict histopathological response to radiochemotherapy in rectal cancer J Surg Res 113 179-88 12957127 10.1016/S0022-4804(03)00049-0 1:CAS:528:DC%2BD3sXmvVOrtrw%3D
10. JE Staunton DK Slonim HA Coller P Tamayo MJ Angelo J Park 2001 Chemosensitivity prediction by transcriptional profiling Proc Natl Acad Sci USA 98 10787-92 11553813 10.1073/pnas.191368598 1:CAS:528:DC%2BD3MXntVGmsL4%3D
11. U Scherf DT Ross M Waltham LH Smith JK Lee L Tanabe 2000 A gene expression database for the molecular pharmacology of cancer Nat Genet 24 236-44 10700175 10.1038/73439 1:CAS:528:DC%2BD3cXhvFaqtrk%3D
12. A Matsuyama H Inoue K Shibuta Y Tanaka GF Barnard K Sugimachi 2001 Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer Cancer Res 61 5714-7 11479204 1:CAS:528:DC%2BD3MXlvVCgtL8%3D
13. M Kusunoki H Yanagi N Kamikonya M Noda T Yamamura 1996 Significant effects of preoperative intraluminal brachytherapy on the survival rate after resection of rectal carcinoma Int J Oncol 9 645-51
14. TR Hughes M Mao AR Jones J Burchard MJ Marton KW Shannon 2001 Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer Nat Biotechnol 19 342-7 11283592 10.1038/86730 1:CAS:528:DC%2BD3MXis1Smsb0%3D
15. LJ van't Veer H Dai MJ van de Vijver YD He AA Hart M Mao 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 530-6 11823860 10.1038/415530a 1:CAS:528:DC%2BD38Xht1Giu7k%3D
16. ZA Jenkins PG Haag HE Johansson 2001 Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression Genomics 71 101-9 11161802 10.1006/geno.2000.6418 1:CAS:528:DC%2BD3MXjvFyguw%3D%3D
17. PM Clement CA Henderson ZA Jenkins Z Smit-McBride EC Wolff JW Hershey 2003 Identification and characterization of eukaryotic initiation factor 5A-2 Eur J Biochem 270 4254-63 14622290 10.1046/j.1432-1033.2003.03806.x 1:CAS:528:DC%2BD3sXovVagsLc%3D
18. D Cao SR Hustinx G Sui P Bala N Sato S Martin 2004 Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags Cancer Biol Ther 3 1081-9 15467436 1:CAS:528:DC%2BD2MXjvFOhsro%3D
19. A Gerard M Buyse B Nordlinger J Loygue F Pene P Kempf 1988 Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC) Ann Surg 208 606-14 3056288 1:STN:280:BiaD2cbis10%3D
20. Swedish Rectal Cancer Trial 1997 Improved survival with preoperative radiotherapy in resectable rectal cancer N Engl J Med 336 980-7 10.1056/ NEJM199704033361402
21. E Kapiteijn CA Marijnen ID Nagtegaal H Putter WH Steup T Wiggers 2001 Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 638-46 11547717 10.1056/ NEJMoa010580 1:STN:280:DC%2BD3Mvps1ektw%3D%3D
22. R Sauer H Becker W Hohenberger C Rodel C Wittekind R Fietkau German Rectal Cancer Study Group 2004 Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-40 15496622 10.1056/NEJMoa040694 1:CAS:528:DC%2BD2cXovFSksbo%3D
23. AL Li HY Li BF Jin QN Ye T Zhou XD Yu 2004 A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis J Biol Chem 279 49251-8 15371445 10.1074/jbc.M407165200 1:CAS:528:DC%2BD2cXpslKisrw%3D
24. X Jiang HE Kim H Shu Y Zhao H Zhang J Kofron 2003 Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway Science 299 223-6 12522243 10.1126/science.1076807 1:CAS:528:DC%2BD3sXhs1Glug%3D%3D
25. F Dominguez C Magdalene E Cancio E Roson J Paredes L Loidi 1993 Tissue concentrations of prothymosin alpha: A novel proliferation index of primary breast cancer Eur J Cancer 29A 893-7 8387320 10.1016/ S0959-8049(05)80433-2 1:STN:280:ByyB2cbnvVI%3D
26. OE Tsitsilonis E Bekris IF Voutsas CN Baxevanis C Markopoulos SA Papadopoulou 1998 The prognostic value of alpha-thymosins in breast cancer Anticancer Res 18 1501-8 9673361 1:STN:280:DyaK1czjvVSkug%3D%3D
27. C Magdalena F Dominguez L Loidi JL Puente 2000 Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer Br J Cancer 82 584-90 10682670 10.1054/bjoc.1999.0968 1:STN:280:DC%2BD3c7ksVyktw%3D%3D
28. M Mori GF Bernard RJ Staniunas JM Jessup GD Steele Jr LB Chen 1993 Prothymosin-alpha mRNA expression correlate with that of c-myc in human colon cancer Oncogene 8 2821-6 8378090 1:CAS:528:DyaK3sXms1OrsrY%3D
29. CG Wu NA Habib RR Mitry PH Reitsma SJ van Deventer RA Chamuleau 1997 Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma Br J Cancer 76 1199-204 9365169 1:STN:280:DyaK1c%2FjtVCmsw%3D%3D
30. H Sasaki M Nonaka Y Fujii Y Yamakawa I Fukai M Kiriyama 2001 Expression of the prothymosin-a gene as a prognostic factor in lung cancer Surg Today 31 936-8 11759895 10.1007/s005950170040 1:CAS:528:DC%2BD3MXpt1Wrtb0%3D
31. S Giagkousiklidis M Vogler MA Westhoff H Kasperczyk KM Debatin S Fulda 2005 Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activation of caspase Cancer Res 65 10502-13 16288043 10.1158/0008-5472.CAN-05-0866 1:CAS:528:DC%2BD2MXht1Wgu7%2FF
32. C Belka V Jendrossek M Pruschy S Vink M Verheij W Budach 2004 Apoptosis-modulating agents in combination with radiotherapy-current status and outlook Int J Radiat Oncol Biol Phys 58 542-54 14751526 10.1016/j.ijrobp.2003.09.067 1:CAS:528:DC%2BD2cXnvVKksg%3D%3D
33. RK Schmidt-Ullrich P Dent S Grant RB Mikkelsen K Valerie 2000 Signal transduction and cellular radiation responses Radiat Res 153 245-57 10669545 10.1667/0033-7587(2000)153[0245:STACRR]2.0.CO;2 1:CAS:528:DC%2BD3cXhvVemt7Y%3D
34. KH Vousden X Lu 2002 Live or let die: The cell's response to p53 Nat Rev Cancer 2 594-604 12154352 10.1038/nrc864 1:CAS:528:DC%2BD38XlslGqsL8%3D